Supreme Court suggests cheaper Covid-19 treatment in smaller towns

The apex court also asked the Centre to consider the aspect of prompt release of claims by insurance companies which cannot keep their hands off at the time of pandemic

coronavirus, coronavirus vaccine
The apex court was told by the Centre that health is a state subject and primary responsibility in terms of management of Covid-19 rests with the states
Press Trust of India New Delhi
2 min read Last Updated : Aug 05 2020 | 11:52 PM IST
The Supreme Court on Wednesday suggested there should be cheaper treatment for Covid-19 patients in smaller towns and asked the Centre to consider the aspect of prompt release of claims by insurance companies which cannot keep their hands off at the time of pandemic.

The apex court was told by the Centre that health is a state subject and primary responsibility in terms of management of Covid-19 rests with the states.

In a report filed in the top court, the Centre proposed that states "may on a priority basis arrive at fair rates for private hospitals to ensure that there is no over-charging from Covid-19 patients or indiscriminate hikes for patients".
A Bench headed by Chief Justice S A Bobde, which was hearing the pleas including the one filed by advocate Sachin Jain who has sought direction for regulating the cost of treatment of Covid-19 at private hospitals across the country, suggested  there should be cheaper treatment for coronavirus infected patients in smaller towns.

The court made the suggestion after counsel appearing for private hospitals said that uniform price capping may not be feasible as it may vary in big and smaller cities.

The Bench, also comprising Justices A S Bopanna and V Ramasubramanian, observed insurance companies cannot keep their hands off at the time of pandemic and the government should consider the aspect of prompt release of dues by them.

The bench was told by an advocate appearing for private hospitals that price capping for Covid-19 treatment should not be made applicable in cases of co-morbidities.

The apex court has posted the matter for further hearing after 15 days.  The Centre, in its report filed in the apex court, has said depending on the number of cases and availability of health infrastructure in government set-up, states may consider exploring utilising health facilities in the private sector.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsSupreme Court

Next Story